Onderneming Innovus Pharmaceuticals Inc OTC Bulletin Board
Aandelen
US45778V1061
Farmaceutische producten
slotkoers
Andere beurzen
|
||
- USD | - |
|
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Joshua Disbrow
CEO | Chief Executive Officer | 49 | - |
Chief Operating Officer | - | 01-06-18 | |
Steven Klayman
PRN | Corporate Officer/Principal | - | - |
Mostafa Abuzeid
PRN | Corporate Officer/Principal | - | - |
Hans Christinger
PRN | Corporate Officer/Principal | - | - |
Gilbert Jaoudé
PRN | Corporate Officer/Principal | - | - |
Corporate Officer/Principal | - | - |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 3 204 401 | 2 483 540 ( 77,50 %) | 0 | 77,50 % |
Bedrijfsgegevens
Innovus Pharmaceuticals, Inc.
373 Inverness Parkway Suite 206
80112, Englewood
+858-964-5123
http://www.innovuspharma.com![Adres Innovus Pharmaceuticals Inc](https://cdn.zonebourse.com/static/address/9598487.png)
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+55,32% | 815 mld. | |
-6,75% | 352 mld. | |
+13,56% | 314 mld. | |
+10,68% | 303 mld. | |
+16,57% | 242 mld. | |
+2,04% | 224 mld. | |
+13,31% | 218 mld. | |
+8,48% | 168 mld. | |
-2,81% | 159 mld. |